About Blue Earth Diagnostics
Blue Earth Diagnostics is a company based in Oxford (United Kingdom) founded in 2014 was acquired by Bracco Imaging in June 2019.. Blue Earth Diagnostics has raised $49.42 million across 2 funding rounds from investors including Syncona and Bracco Imaging. The company has 38 employees as of December 31, 2021. Blue Earth Diagnostics has completed 1 acquisition, including Bracco Imaging. Blue Earth Diagnostics offers products and services including PET Radiopharmaceuticals, Axumin, and Posluma. Blue Earth Diagnostics operates in a competitive market with competitors including Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
- Headquarter Oxford, United Kingdom
- Employees 38 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Blue Earth Diagnostics Limited
- Date of Incorporation 13 Nov, 2013
- Jurisdiction OXFORD, UNITED KINGDOM
-
Annual Revenue
$311.88 (USD)-100as on Dec 31, 2017
-
Net Profit
$-1.75 K (USD)35as on Dec 31, 2017
-
EBITDA
-
Total Equity Funding
$49.42 M (USD)
in 2 rounds
-
Latest Funding Round
$28.07 M (USD), Series B
Jul 23, 2015
-
Investors
Syncona
& 1 more
-
Employee Count
38
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
Bracco Imaging
(Jun 27, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blue Earth Diagnostics
Blue Earth Diagnostics offers a comprehensive portfolio of products and services, including PET Radiopharmaceuticals, Axumin, and Posluma. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Radiopharmaceuticals for PET imaging in cancer detection
Agent for prostate cancer imaging via PET scans
Agent for prostate-specific membrane antigen imaging
Funding Insights of Blue Earth Diagnostics
Blue Earth Diagnostics has successfully raised a total of $49.42M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $28.07 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $28.1M
-
First Round
First Round
(11 Mar 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Series B - Blue Earth Diagnostics | Valuation |
investors |
|
| Mar, 2014 | Amount | Series A - Blue Earth Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Blue Earth Diagnostics
Blue Earth Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Syncona and Bracco Imaging. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location | |
|
A portfolio of medical imaging devices for diagnostics is provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Blue Earth Diagnostics
Blue Earth Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bracco Imaging. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A portfolio of medical imaging devices for diagnostics is provided.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Blue Earth Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Blue Earth Diagnostics Comparisons
Competitors of Blue Earth Diagnostics
Blue Earth Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Blue Earth Diagnostics
Frequently Asked Questions about Blue Earth Diagnostics
When was Blue Earth Diagnostics founded?
Blue Earth Diagnostics was founded in 2014.
Where is Blue Earth Diagnostics located?
Blue Earth Diagnostics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Blue Earth Diagnostics a funded company?
Blue Earth Diagnostics is a funded company, having raised a total of $49.42M across 2 funding rounds to date. The company's 1st funding round was a Series A of $21.36M, raised on Mar 11, 2014.
How many employees does Blue Earth Diagnostics have?
As of Dec 31, 2021, the latest employee count at Blue Earth Diagnostics is 38.
What is the annual revenue of Blue Earth Diagnostics?
Annual revenue of Blue Earth Diagnostics is $311.88 as on Dec 31, 2017.
What does Blue Earth Diagnostics do?
Founded in 2014 and based in Oxford, United Kingdom, radioactive molecular imaging agents for cancer detection and therapy are developed by the company. Operations center on synthetic amino acid derivatives and PSMA-targeted compounds used in PET imaging. Fluciclovine (18F) is employed for prostate cancer and brain metastases visualization, while rhPSMA-7.c supports PET scanning for prostate cancer, and rhPSMA facilitates radiopharmaceutical therapy in the same area.
Who are the top competitors of Blue Earth Diagnostics?
Blue Earth Diagnostics's top competitors include Guardant Health, Strand Life Sciences and Juno Therapeutics.
What products or services does Blue Earth Diagnostics offer?
Blue Earth Diagnostics offers PET Radiopharmaceuticals, Axumin, and Posluma.
How many acquisitions has Blue Earth Diagnostics made?
Blue Earth Diagnostics has made 1 acquisition, including Bracco Imaging.
Who are Blue Earth Diagnostics's investors?
Blue Earth Diagnostics has 2 investors. Key investors include Syncona, and Bracco Imaging.